Abiogen Pharma has a longstanding tradition in the dermatological area and over the years has strived to support both dermatologists and general practitioners by providing therapeutic solutions for different skin disorders.
In the dermatological area, Abiogen Pharma has acquired visibility on the national scene with the clinical development of a topical therapy for psoriasis, which has been followed by the introduction of an antioxidant therapy and one for atopic dermatitis with an innovative formulation and a high degree of cosmeticity.
Psoriasis is a chronic illness that can have a considerable physical impact, though it is worth remembering that it is not merely an aesthetical problem and that even people with mild form recognize the negative effects it has on their everyday lives. It is therefore important that the patient can have access to therapeutic solutions that guarantee an excellent level of compliance.
Psoriasis is associated with several significant medical conditions, including depression, psoriatic arthritis, and cardio-metabolic syndrome. Its most common form, chronic plaque psoriasis or psoriasis vulgaris, is a result of genetic predisposition and environmental factors such as streptococcal infection, stress, smoking, obesity, and alcohol consumption.
Currently, there is no causal therapy, but its management aims to minimize both the physical and psychological damage by treating patients in the early stages of the pathological process, identifying and preventing associated comorbidities, encouraging lifestyle changes, and employing a personalized treatment approach.
Atopic dermatitis is a skin disease characterised by recurrent eczematous lesions and intense itching as primary symptoms.
Atopic dermatitis is the most widespread chronic inflammatory skin condition globally. It has a significant impact on the lives of both children and adults, and it also affects those who care for patients and their families.
While not entirely understood, its pathogenesis is complex and appears to result from a combination of genetic and environmental factors that induce dysfunction of the skin barrier, cutaneous and systemic immune dysregulation, dysbiosis of the skin microbiota, and a strong genetic influence.
Diagnosis is based on specific criteria that consider the patient’s and family’s medical history and clinical manifestations.